跳到主要內容

Ryan Arthur F 的 Form 4 申報

Regeneron Pharmaceuticals, Inc.(REGN),2022/11/3 申報

申報編號
0001883850-22-000088
申報時間
2022/11/3
交易日
2022/11/1
申報延遲
2 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 10 筆非衍生性交易。公開市場賣出合計 $7.56 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Ryan Arthur FCIK 0001187443董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/11/1Common StockS賣出處分−2$750.00−$1,50019,480直接
2022/11/1Common StockS賣出處分−6$752.59F2−$4,515.5419,474直接
2022/11/1Common StockS賣出處分−10$753.68F3−$7,536.819,464直接
2022/11/1Common StockS賣出處分−12$754.73F4−$9,056.7619,452直接
2022/11/1Common StockS賣出處分−18$755.50F5−$13,59919,434直接
2022/11/1Common StockS賣出處分−26$756.31F6−$19,664.0619,408直接
2022/11/1Common StockS賣出處分−15$757.58F7−$11,363.719,393直接
2022/11/1Common StockS賣出處分−4$758.16F8−$3,032.6419,389直接
2022/11/1Common StockS賣出處分−5$759.61F9−$3,798.0519,384直接
2022/11/1Common StockS賣出處分−2$761.00−$1,52219,382直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

Represents volume-weighted average price of sales of 6 shares of Company stock on November 1, 2022 at prices ranging from $752.28 to $752.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents volume-weighted average price of sales of 10 shares of Company stock on November 1, 2022 at prices ranging from $753.23 to $753.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents volume-weighted average price of sales of 12 shares of Company stock on November 1, 2022 at prices ranging from $754.06 to $754.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents volume-weighted average price of sales of 18 shares of Company stock on November 1, 2022 at prices ranging from $755.11 to $755.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents volume-weighted average price of sales of 26 shares of Company stock on November 1, 2022 at prices ranging from $756.01 to $756.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents volume-weighted average price of sales of 15 shares of Company stock on November 1, 2022 at prices ranging from $757.00 to $757.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F8

Represents volume-weighted average price of sales of 4 shares of Company stock on November 1, 2022 at prices ranging from $758.05 to $758.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F9

Represents volume-weighted average price of sales of 5 shares of Company stock on November 1, 2022 at prices ranging from $759.00 to $759.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 1, 2022 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)